All In MedTech

FDA Clearance Tracker · K152088

IV-eye

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Feb 24, 2016 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Feb 24, 2016

Substantially Equivalent

Time to decision

212 days

Received Jul 27, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class I

The decision

FDA number
K152088
Device name
IV-eye
Applicant location
Abingdon, GB
Received
Jul 27, 2015
Decided
Feb 24, 2016
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class I
Regulation
21 CFR 880.6970

Every decision under product code KZA

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code KZA. The earliest in FDA's data is K780884, decided Aug 10, 1978.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Novarix Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.